I said to sell and short AFFY near $16 this month, ... "If any negative news come from the results, AFFY will go back to single digits."
Now, the negative news, the extremely bad news came out. AFFY will go to single digits for sure.
My old fellows should know that I said to buy AFFY at $6's before and predicted it would go to double digits. It reached $27 last year.
I did not touch AFFY after I locked the profits in the run-up (last year) until this month (on Feb 14). I made a sell call near $16 based on the news at that time. I also told you guys not to risk the profits that you had made from AFFY before.
It is your responsibility if you are still holding the shares. If you are standing on my side and holding the short positions, time to pay off big tomorrow.
"... It's important to note that Fresenius has put the brakes on expanding the use of Omontys in additional dialysis centers while it looks at the data from the pilot -- but it will continue using Omontys in the meantime. In fact, according to an 8-K form filed by Affymax today, Fresenius stated that "The vast majority of patients who are receiving the medication on an ongoing monthly basis are tolerating it well" and "For patients on Omontys, we recommend continued use of the agent as it has been providing effective anemia management." ...
If you believed the above facts and are still holding AFFY, you are not thinking outside the box.
I posted my feeling & prediction based on the announcement of the news at that time. Feeling comes from experiences and it has been proved again, within 10 days.